Skip to search formSkip to main contentSkip to account menu

MammaPrint

Known as: Agendia 
MammaPrint is a diagnostic test to assess the risk that a breast tumor will metastasize to other parts of the body. This helps physicians determine… 
Wikipedia (opens in a new tab)

Related topics

Related topics

1 relation
Microarray

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Abstract P4-08-12: Comparative analyses of the prognostic value of oncotype and mammaprint using the National Cancer Database
INTRODUCTION: Majority of the approximately 40,610 deaths from metastatic breast cancer in the US each year occur in women with… 
2015
2015
A head-to-head comparison of Mammaprint and Oncotype Dx: A McGill University Health Center Experience.
11017 Background: The Objective of our study was to investigate the concordance of patient results from a single university… 
Review
2015
Review
2015
HEALTH EVIDENCE REVIEW COMMISSION (HERC) COVERAGE GUIDANCE: BIOMARKER TESTS OF CANCER TISSUE FOR PROGNOSIS AND POTENTIAL RESPONSE TO TREATMENT
  • 2015
  • Corpus ID: 46235270
Oncotype DX is recommended for coverage in early stage breast cancer when used to guide adjuvant chemotherapy treatment decisions… 
2014
2014
Aberto processo seletivo para monitoria na Agêndia Da Hora
2014
2014
EVALUAR LOS PERFILES DE EXPRESIÓN GENÉTICA CON LA PRUEBA MAMMAPRINT Y TARGET PRINT CON INMUNOHISTOQUÍMICA
SUMMARY OBJECTIVE: We show our experience with test of 70 genes (Mammaprint ® ), in evaluation and the treatment patients with… 
2013
2013
The prospective MammaPrint MINT (Multi-Institutional Neo-adjuvant Therapy) study.
TPS11122 Background: Patients with locally advanced breast cancer (LABC) are often treated with neo-adjuvant chemotherapy to… 
2011
2011
Experiencia en la utilización del mammaprint en la Clínica de mamas de Barquisimeto
The objective of this work was information of genetic characteristics of tumor, determined by methods such as mamma print… 
Review
2009
Review
2009
Imaging , Diagnosis , Prognosis Microarray-Based Determination of Estrogen Receptor , Progesterone Receptor , and HER 2 Receptor Status in Breast Cancer
Purpose: The level of estrogen receptor (ER), progesterone receptor (PR), and HER2 aids in the determination of prognosis and… 
2009
2009
Benefit of the 70-gene profile for widely used guidelines: an answer to increased selection for adjuvant chemotherapy in breast cancer.
Risk assessment for breast cancer patients differs substantially among treatment guidelines. The NCCN, St.Gallen, Adjuvant!Online… 
Review
2008
Review
2008
Progress in targeted therapies for cancer: overview
The explosion in knowledge about the molecular and cellular biology of cancer has led to the identification of many molecules or… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)